Discovery of a highly potent novel rifampicin analog by preparing a hybrid of the precursors of the antibiotic drugs rifampicin and clofazimine
Abstract Tuberculosis (TB) is an infectious disease caused by the bacillus Mycobacterium tuberculosis (Mtb). The present work reports the design and synthesis of a hybrid of the precursors of rifampicin and clofazimine, which led to the discovery of a novel Rifaphenazine (RPZ) molecule with potent a...
Guardado en:
Autores principales: | Pasupathy Saravanan, V. N. Azger Dusthackeer, R. S. Rajmani, B. Mahizhaveni, Christy R. Nirmal, Sam Ebenezer Rajadas, Neerupma Bhardwaj, C. Ponnuraja, Adhin Bhaskar, A. K. Hemanthkumar, Geetha Ramachandran, Srikanth P. Tripathy |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/56b9adfff36d4fa4b354549045157315 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The relevancy of controlled nanocrystallization on rifampicin characteristics and cytotoxicity
por: Mohyeldin SM, et al.
Publicado: (2016) -
Predictors of unfavorable responses to therapy in rifampicin-sensitive pulmonary tuberculosis using an integrated approach of radiological presentation and sputum mycobacterial burden.
por: Narendran Gopalan, et al.
Publicado: (2021) -
Genomic epidemiology of rifampicin ADP-ribosyltransferase (Arr) in the Bacteria domain
por: Sergio Morgado, et al.
Publicado: (2021) -
Characterization of rifampicin-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan
por: Anwar Sheed Khan, et al.
Publicado: (2021) -
Rifampicin-Induced Nephrotoxicity in a Tuberculosis Patient: Treatment Dilemma?
por: Antonio Grilo Novais, et al.
Publicado: (2021)